News und Analysen
Portfolio company Disc Medicine raises $157.8 million in public offering
Portfolio company Disc Medicine raises $157.8 million in public offering
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Merger of Heliad Equity Partners GmbH & Co. KGaA into FinLab AG: Mutual Understanding on exchange ratio
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Merger of Heliad Equity Partners GmbH & Co. KGaA into FinLab AG: Mutual Understanding on exchange ratio
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Plans of Merger with FinLab AG
Portfolio company Ensoma announces closing of Series B Extension
Portfolio company Ensoma announces closing of Series B Extension
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Full Year results now to be released on 25 April 2023
Full Year results now to be released on 25 April 2023
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Razor Group Acquires Stryze Group and Secures Further Equity Investment to Strengthen its Position as Leading E-Commerce Aggregator
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA successfully completes capital increase.
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
EQS-Adhoc: Heliad Equity Partners GmbH & Co. KGaA: Heliad Equity Partners GmbH & Co. KGaA resolves cash capital increase with subscription rights of up to 1,818,181 new shares (~16.2 percent of share capital)
Portfolio company Disc Medicine announces $62.5 million financing
Portfolio company Disc Medicine announces $62.5 million financing
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
EQS-News: Heliad Equity Partners GmbH & Co. KGaA: Enpal closes its Series D round with €200 million in equity
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma